NA
LMAT icon

NewEdge Advisors’s LeMaitre Vascular LMAT Stock Holding History

NewEdge Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Sell
2,291
-16
-0.7% -$1.64K ﹤0.01% 2711
2026
Q1 		$252K Sell
2,307
-851
-27% -$81.1K ﹤0.01% 2463
2025
Q4 		$256K Buy
3,158
+139
+5% +$12K ﹤0.01% 2422
2025
Q3 		$264K Buy
3,019
+86
+3% +$7.68K ﹤0.01% 2256
2025
Q2 		$244K Buy
2,933
+2,641
+904% +$221K ﹤0.01% 2122
2025
Q1 		$24.5K Hold
292
– – ﹤0.01% 2793
2024
Q4 		$26.9K Hold
292
– – ﹤0.01% 2719
2024
Q3 		$27.1K Hold
292
– – ﹤0.01% 2630
2024
Q2 		$24K Sell
292
-79
-21% -$5.8K ﹤0.01% 2576
2024
Q1 		$24.6K Buy
371
+79
+27% +$4.88K ﹤0.01% 2561
2023
Q4 		$16.6K Buy
292
+257
+734% +$13.5K ﹤0.01% 2646
2023
Q3 		$1.91K Sell
35
-89
-72% -$5.27K ﹤0.01% 3062
2023
Q2 		$8.35K Buy
124
+33
+36% +$2.01K ﹤0.01% 2658
2023
Q1 		$4.69K Sell
91
-610
-87% -$29.6K ﹤0.01% 2799
2022
Q4 		$28.1K Buy
+701
New +$32.8K ﹤0.01% 1993

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

NewEdge Advisors's LMAT Position: Q2 2026 in Review

NewEdge Advisors reduced its LeMaitre Vascular (LMAT) stake by 0.69% in Q2 2026, selling an estimated $1.64K and leaving 2,291 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

NewEdge Advisors first reported a position in LMAT in Q4 2022 and has held it in 15 quarters since. The position peaked at $264K in Q3 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • NewEdge Advisors held 2,291 shares of LeMaitre Vascular worth $220K as of Q2 2026.
  • NewEdge Advisors sold 16 LeMaitre Vascular shares in Q2 2026, an estimated $1.64K.
  • LeMaitre Vascular made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2711 holding.
  • NewEdge Advisors first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 15 quarters since.
  • NewEdge Advisors's LeMaitre Vascular position peaked at $264K in Q3 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.